Detalles de la búsqueda
1.
Development of a national health policy logic model to accelerate the integration of oncology and palliative care: a nationwide Delphi survey in Japan.
Int J Clin Oncol;
27(9): 1529-1542, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35713754
2.
Phase II study of carboplatin-paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024.
Int J Clin Oncol;
27(4): 676-683, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35092535
3.
Inhibition of nonsense-mediated decay rescues p53ß/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers.
J Biol Chem;
297(5): 101163, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34481841
4.
Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401).
Thorac Cancer;
12(14): 2113-2121, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34076966
5.
Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302.
Int J Clin Oncol;
26(3): 515-522, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33184754
6.
Elemental and mutational analysis of lung tissue in lung adenocarcinoma patients.
Transl Lung Cancer Res;
8(Suppl 3): S224-S234, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31857947
7.
Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer.
Cancer Discov;
9(5): 646-661, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30777870
8.
A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101).
Int J Clin Oncol;
23(6): 1060-1069, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30027464
9.
Antiproteinuric effects of renin-angiotensin inhibitors in lung cancer patients receiving bevacizumab.
Cancer Chemother Pharmacol;
81(6): 1051-1059, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29651572
10.
Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naïve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901.
Lung Cancer;
111: 38-42, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28838395
11.
Case series on the association between blood levels and side effects of afatinib maleate.
Cancer Chemother Pharmacol;
80(3): 545-553, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28718011
12.
Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials.
Front Pharmacol;
8: 972, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29387008
13.
Analysis of a single-codon E746 deletion in exon 19 of the epidermal growth factor receptor.
Cancer Chemother Pharmacol;
77(5): 1019-29, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27042857
14.
Feasibility study of short hydration using oral rehydration solution in cisplatin including chemotherapy of lung cancer.
J Pharm Health Care Sci;
2: 6, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26949541
15.
Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702.
Lung Cancer;
89(1): 61-5, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26004087
16.
[Folate antagonist].
Nihon Rinsho;
73 Suppl 2: 146-8, 2015 Feb.
Artículo
en Japonés
| MEDLINE | ID: mdl-25831740
17.
First-line gefitinib for elderly patients with advanced NSCLC harboring EGFR mutations. A combined analysis of North-East Japan Study Group studies.
Expert Opin Pharmacother;
16(4): 465-72, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25597331
18.
A phase II study of erlotinib monotherapy in pre-treated non-small cell lung cancer without EGFR gene mutation who have never/light smoking history: re-evaluation of EGFR gene status (NEJ006/TCOG0903).
Lung Cancer;
86(2): 195-200, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25249428
19.
Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer: North Japan Lung Cancer Group Trial 0802.
Respir Investig;
52(3): 190-4, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24853020
20.
Randomized phase II trial comparing carboplatin plus weekly paclitaxel and docetaxel alone in elderly patients with advanced non-small cell lung cancer: north japan lung cancer group trial 0801.
Oncologist;
19(4): 352-3, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24682465